Isha Ambani and Nandini Piramal

Nandini Piramal is an influential leader within the Piramal Group, a prominent Indian conglomerate with diverse business interests. The Piramal family has a significant entrepreneurial heritage, with Nandini playing a pivotal role in the company’s growth. She is the daughter of Ajay Piramal, a well-known figure in the pharmaceutical sector, and Dr. Swati Piramal. Piramal Group’s business spans pharmaceuticals, financial services, real estate and social initiatives through the Piramal Foundation.

Nandini is the Chief Executive Officer of Piramal Enterprises Limited where she heads various key functions. One of her major responsibilities is overseeing the Over-The-Counter (OTC) business segment. Under her leadership, the OTC division has become one of the fastest growing in India, with many of its products leading their respective categories. In addition, she leads Human Resources and Information Technology at the Piramal Group and is responsible for the Quality and Risk functions in the pharmaceutical sector. Her efforts are instrumental in driving growth and operational efficiency within the organization.

A significant milestone in Nandini’s career came in 2010 when she was instrumental in the sale of the Piramal Group’s domestic formulations business to Abbott Laboratories. This transaction, valued at $3.8 billion (approximately Rs 31,638 crore), marked one of the largest transactions in the Indian pharmaceutical sector at the time and enabled the group to diversify and expand into new ventures.

Educationally, Nandini has a strong academic background. She holds a BA in Politics, Philosophy and Economics from Oxford University, England, and an MBA from Stanford University Graduate School of Business, California. Her work experience includes a stint as a business analyst at McKinsey & Company before joining the family business in 2006.

Nandini’s personal life is also intertwined with the business world. In 2009, she married Peter DeYoung, who is currently the CEO of Piramal Global Pharma and an executive director at Piramal Pharma. Peter, a fellow Stanford graduate, also has an engineering background from Princeton University and previously worked with McKinsey & Company.

Although Nandini’s personal net worth is not publicly disclosed, the wealth of the Piramal family is substantial. Her father Ajay Piramal has an estimated net worth of USD 2.8 billion (approximately Rs 23,307 crore). In FY2023, Piramal Group reported a consolidated revenue of Rs 9,087 crore, indicating its significant presence in the Indian market.